THE NUCLEAR RECEPTOR LRH-1 IS A THERAPEUTIC TARGET FOR INFLAMMATORY BOWEL DISEASE (IBD)

被引：0
|
作者：
Wang, Hongtao
Wang, Guohui
Moore, David D.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1881
引用
收藏
页码：S647 / S648
页数：2
相关论文
共 50 条
  • [21] Docking studies of the orphan nuclear receptor LRH-1: A potential target for tissue specific cancer therapy.
    Aynechi, T
    Ingraham, HA
    Kuntz, ID
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U446 - U446
  • [22] The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion
    Chand, A. L.
    Herridge, K. A.
    Thompson, E. W.
    Clyne, C. D.
    ENDOCRINE-RELATED CANCER, 2010, 17 (04) : 965 - 975
  • [23] Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation
    Lee, YK
    Choi, YH
    Chua, S
    Park, YJ
    Moore, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (12) : 7850 - 7855
  • [24] Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)
    Verstockt, Sare
    Verstockt, Bram
    Vermeire, Severine
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (11) : 943 - 954
  • [25] GCPII as a Therapeutic Target for Inflammatory Bowel Disease (IBD): Expression in Human IBD Versus Preclinical Colitis Models
    Zhi, Sabrina
    Zhang, Sophia
    Pradhan, Manisha
    Slusher, Barbara
    Peters, Diane
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (03):
  • [26] Therapeutic strategy for biotherapies in inflammatory bowel disease (IBD)
    Ayach, L.
    Ponrouch, M. -P.
    Rosant, D.
    Altwegg, R.
    Roch-Torreilles, I.
    Pageaux, G. -P.
    Rambourg, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 547 - 547
  • [27] The Medicinal Chemistry and Therapeutic Potential of LRH-1 Modulators
    Lang, Alisa
    Isigkeit, Laura
    Schubert-Zsilavecz, Manfred
    Merk, Daniel
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 16956 - 16973
  • [28] Interleukin-1 beta converting enzyme (ICE): A novel therapeutic target in inflammatory bowel disease (IBD).
    McAlindon, ME
    Mahida, YR
    GASTROENTEROLOGY, 1996, 110 (04) : A961 - A961
  • [29] Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1
    Sablin, EP
    Krylova, IN
    Fletterick, RJ
    Ingraham, HA
    MOLECULAR CELL, 2003, 11 (06) : 1575 - 1585
  • [30] TL1A as a therapeutic target in inflammatory bowel disease
    Kokkotis, Georgios
    Bamias, Giorgos
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (06) : 551 - 555
12345